- Home
- LSB vs ECF Comparison
LSB vs ECF Comparison
Compare LSB & ECF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LSB
- ECF
- Stock Information
- Founded
- LSB 2002
- ECF 1986
- Country
- LSB China
- ECF United States
- Employees
- LSB N/A
- ECF N/A
- Industry
- LSB
- ECF Finance/Investors Services
- Sector
- LSB
- ECF Finance
- Exchange
- LSB NYSE
- ECF Nasdaq
- Market Cap
- LSB 49.8M
- ECF 136.5M
- IPO Year
- LSB N/A
- ECF N/A
- Fundamental
- Price
- LSB $2.96
- ECF $9.58
- Analyst Decision
- LSB
- ECF
- Analyst Count
- LSB 0
- ECF 0
- Target Price
- LSB N/A
- ECF N/A
- AVG Volume (30 Days)
- LSB 22.5K
- ECF 57.7K
- Earning Date
- LSB 01-21-2025
- ECF 01-01-0001
- Dividend Yield
- LSB N/A
- ECF 6.42%
- EPS Growth
- LSB N/A
- ECF N/A
- EPS
- LSB N/A
- ECF 0.46
- Revenue
- LSB $79,415,311.00
- ECF N/A
- Revenue This Year
- LSB $39.33
- ECF N/A
- Revenue Next Year
- LSB $75.61
- ECF N/A
- P/E Ratio
- LSB N/A
- ECF $17.61
- Revenue Growth
- LSB N/A
- ECF N/A
- 52 Week Low
- LSB $1.88
- ECF $7.02
- 52 Week High
- LSB $11.20
- ECF $8.91
- Technical
- Relative Strength Index (RSI)
- LSB 55.32
- ECF 42.15
- Support Level
- LSB $2.10
- ECF $9.48
- Resistance Level
- LSB $2.77
- ECF $9.93
- Average True Range (ATR)
- LSB 0.37
- ECF 0.10
- MACD
- LSB 0.04
- ECF -0.06
- Stochastic Oscillator
- LSB 61.40
- ECF 18.18
About LSB LAKESHORE BIOPHARMA CO LTD
LakeShore Biopharma Co Ltd is a biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious diseases and cancer. It has developed a proprietary PIKA immunomodulating technology platform and a new generation of preventive and therapeutic biologics targeting Rabies, Coronavirus, Hepatitis B, Influenza, Shingles, and other virus infections. The company operates in China, the United States, Singapore, and the Philippines.
About ECF Ellsworth Growth and Income Fund Ltd.
Ellsworth Growth and Income Fund Ltd operate as a closed-end, diversified management investment company. Its investment objective is to provide income and the potential for capital appreciation, which objectives the Fund considers to be relatively equal over the long term due to the nature of the securities in which it invests. The company invests in convertible and equity securities. It invests in various sectors, such as healthcare, financial services, computer software and services, energy and utilities, real estate investment trusts, semiconductors, telecommunications, business services, food and beverage, consumer products, transportation, consumer services among others.